The role of mucus in cough research

Lung

Volumn 188, Issue SUPPL., 2010, Pages

  Rubin, Bruce K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cough; Expectorants; Mucins; Mucolytics; Mucus; Phlegm; Rheology; Sputum; Tenacity

Indexed keywords

ACETYLCYSTEINE; DENUFOSOL; DORNASE ALFA; EXPECTORANT AGENT; MANNITOL; MUCOLYTIC AGENT;

BIOPHYSICS; CHRONIC DISEASE; CILIARY MOTILITY; CONFERENCE PAPER; COUGHING; CYSTIC FIBROSIS; HUMAN; INFECTION; INFLAMMATION; INFLAMMATORY CELL; MEDICAL RESEARCH; MUCOCILIARY CLEARANCE; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; SURFACE PROPERTY;

ANTITUSSIVE AGENTS; COUGH; EXPECTORANTS; HUMANS; MUCOCILIARY CLEARANCE; MUCUS; RESEARCH; RHEOLOGY; SPUTUM; SURFACE PROPERTIES; VISCOSITY;

EID: 77949267671     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-009-9198-7     Document Type: Conference Paper

References (37)

1. M King JM Zahm D Pierrot S Vaquez-Girod E Puchelle 1989 The role of mucus gel viscosity, spinnability, and adhesive properties in clearance by simulated cough Biorheology 26 737 745 1:STN:280:DyaK3c7itlWjug%3D%3D 2611367
2. Rubin BK (1998) Surface properties of respiratory secretions: relationship to mucus transport. In: Baum G, Priel Z, Roth Y, Liron N, Ostfield E (eds) Cilia, mucus, and mucociliary interactions. Marcel Dekker, New York, pp 317-323
3. BK Rubin 2009 Mucus, phlegm, and sputum in cystic fibrosis Respir Care 54 726 732 19467160
4. JA Voynow BK Rubin 2009 Mucus, mucins, and sputum Chest 135 505 512 10.1378/chest.08-0412 1:CAS:528:DC%2BD1MXjsVeru7s%3D 19201713
5. MO Henke A Renner RM Huber MC Seeds BK Rubin 2004 MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions Am J Respir Cell Mol Biol 31 86 91 10.1165/rcmb.2003-0345OC 1:CAS:528:DC%2BD2cXlsFKjsbo%3D 14988081 (Pubitemid 38888043)
6. King M, Rubin BK (1994) Mucus rheology, relationship with transport. In: Takaishima T (ed) Airway secretion: physiological bases for the control of mucus hypersecretion, chap 7. Marcel Dekker, New York, pp 283-314
7. AA Hassan CA Evrensel PE Krumpe 2006 Clearance of viscoelastic mucus simulant with airflow in a rectangular channel, an experimental study Technol Health Care 14 1 11 16556959
8. A Kater MO Henke BK Rubin 2007 The role of DNA and actin polymers on the polymer structure and rheology of cystic fibrosis sputum and depolymerization by gelsolin or thymosin Beta 4 Ann N Y Acad Sci 1112 140 153 10.1196/annals.1415. 006 1:CAS:528:DC%2BD2sXhtlWntrvJ 17496063 (Pubitemid 47598647)
9. M Agarwal M King BK Rubin JB Shukla 1989 Mucus transport in a miniaturized simulated cough machine: effect of constriction and serous layer simulant Biorheology 26 977 988 1:STN:280:DyaK3c7mslalsA%3D%3D 2624896
10. Ragavan AJ, Evrensel CA, Krumpe P (2009) Interactions of airflow oscillation, tracheal inclination and elasticity significantly improve mucus clearance during simulated cough. Chest (in press)
11. Tomkiewicz RP, Kishioka C, Freemann J, Rubin BK (1998) DNA and actin filaments ultrastructure in cystic fibrosis sputum. In: Baum GL, Priel Z, Roth Y, Liron N, Ostfield E (eds) Cilia, mucus, and mucociliary interactions. Marcel Dekker, New York, pp 333-341
12. JS Kim K Okamoto BK Rubin 2006 Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis Chest 129 1148 1154 10.1378/chest.129.5.1148 1:CAS:528:DC%2BD28XlsVekt7g%3D 16685004
13. MT Lopez-Vidriero L Reid 1978 Chemical markers of mucous and serum glycoproteins and their relation to viscosity in mucoid and purulent sputum from various hypersecretory diseases Am Rev Respir Dis 117 465 477 1:CAS:528:DyaE1cXhs1yjsL8%3D 629481
14. RP Tomkiewicz GM Albers OE Ramirez F Green M King BK Rubin 1995 Rheologic properties of airway secretions in cystic fibrosis, chronic bronchitis, and fatal asthma Biorheology 32 364 365 10.1016/0006-355X(95)92361-D
15. GM Albers RP Tomkiewicz MK May OE Ramirez BK Rubin 1996 Ring distraction technique for measuring surface tension of sputum: relationship to sputum clearability J Appl Physiol 81 6 2690 2695 1:STN:280:DyaK2s7ntFaqtg%3D%3D 9018523
16. Rubin BK (2004) Taxonomy of mucoactive medications. In: Rubin BK, van der Schans CP (eds) Therapy for mucus clearance disorders. Marcel Dekker, New York, pp 129-146
17. BK Rubin 2007 Mucolytics, expectorants, and mucokinetic medications Respir Care 52 859 865 17594730
18. F Ratjen 2008 Recent advances in cystic fibrosis Paediatr Respir Rev 9 144 148 10.1016/j.prrv.2008.01.004 1:STN:280:DC%2BD1czltVynsw%3D%3D 18513677
19. SH Donaldson WD Bennett KL Zeman MR Knowles R Tarran RC Boucher 2006 Mucus clearance and lung function in cystic fibrosis with hypertonic saline N Engl J Med 354 241 250 10.1056/NEJMoa043891 1:CAS:528:DC%2BD28Xls1Gkug%3D%3D 16421365 (Pubitemid 43113029)
20. D Pavia ML Thomson SW Clarke 1978 Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol Am Rev Respir Dis 117 199 203 1:STN:280:DyaE1c7kt1yqtQ%3D%3D 637404
21. C Kishioka K Okamoto JS Kim BK Rubin 2003 Hyperosmolar solutions stimulate mucus secretion in the ferret trachea Chest 124 306 313 10.1378/chest.124.1.306 1:CAS:528:DC%2BD3sXmsFClt7w%3D 12853538 (Pubitemid 36851367)
22. BK Rubin O Ramirez JA Ohar 1996 Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis Chest 109 348 352 10.1378/chest.109.2.348 1:STN:280:DyaK287oslKmsA%3D%3D 8620704
23. C Shim M King MH Williams Jr 1987 Lack of effect of hydration on sputum production in chronic bronchitis Chest 92 679 682 10.1378/chest.92.4.679 1:STN:280:DyaL1c%2FgtlKlsA%3D%3D 3652753
24. LC Marchette BE Marchette WM Abraham A Wanner 1985 The effect of systemic hydration on normal and impaired mucociliary function Pediatr Pulmonol 1 107 111 10.1002/ppul.1950010209 1:STN:280:DyaL28%2Fms1yntQ%3D%3D 4069794
25. R Deterding G Retsch-Bogart L Milgram R Gibson C Daines PL Zeitlin C Milla B Marshall L Lavange J Engels D Mathews J Gorden A Schaberg J Williams B Ramsey Cystic Fibrosis Foundation Therapeutics Development Network 2005 Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis Pediatr Pulmonol 39 339 348 10.1002/ppul.20192 15704203 (Pubitemid 40411534)
26. HJ Fuchs DS Borowitz DH Christiansen EM Morris ML Nash BW Ramsey BJ Rosenstein AL Smith ME Wohl 1994 Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group N Engl J Med 331 637 642 10.1056/NEJM199409083311003 1:STN:280:DyaK2czivFWgsQ%3D%3D 7503821 (Pubitemid 24276863)
27. BK Rubin 2007 Mucus structure and properties in cystic fibrosis Paediatr Respir Rev 8 4 7 10.1016/j.prrv.2007.02.004 17419972 (Pubitemid 46523785)
28. BK Rubin 1999 Who will benefit from DNase? Pediatr Pulmonol 27 3 4 10.1002/(SICI)1099-0496(199901)27:1<3::AID-PPUL2>3.0.CO;2-A 1:STN:280:DyaK1M7ks1eruw%3D%3D 10023784 (Pubitemid 29063794)
29. BK Rubin AP Kater AL Goldstein 2006 Thymosin β4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro Chest 130 1433 1440 10.1378/chest.130.5.1433 17099021 (Pubitemid 44786737)
30. M Decramer M Rutten-van Molken PN Dekhuijzen T Troosters C van Herwaarden R Pellegrino CP van Schayck D Olivieri M Del Donno W De Backer I Lankhorst A Ardia 2005 Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial Lancet 365 1552 1560 10.1016/S0140-6736(05) 66456-2 1:CAS:528:DC%2BD2MXjvVKru7c%3D 15866309 (Pubitemid 40615404)
31. G Zayas JC Valle M Alonso H Alfaro D Vega G Bonilla M Reyes M King 2007 A new paradigm in respiratory hygiene: modulating respiratory secretions to contain cough bioaerosol without affecting mucus clearance BMC Pulm Med 7 11 10.1186/1471-2466-7-11 17697323 (Pubitemid 47471183)
32. K Morgenroth J Bolz 1985 Morphological features of the interaction between mucus and surfactant on the bronchial mucosa Respiration 47 225 231 10.1159/000194774 1:STN:280:DyaL2M3hslyitg%3D%3D 3839090
33. V Im Hof P Gehr V Gerber MM Lee S Schürch 1997 In vivo determination of surface tension in the horse trachea and in vitro model studies Respir Physiol 109 81 93 10.1016/S0034-5687(97)84032-7 1:STN:280:DyaK2svhslOmsA%3D%3D 9271810 (Pubitemid 27327002)
34. A Anzueto A Jubran JA Ohar CA Piquette SI Rennard G Colice EN Pattishall J Barrett M Engle KA Perret BK Rubin 1997 Effects of aerosolized surfactant in patients with stable chronic bronchitis. A prospective randomized controlled trial JAMA 278 1426 1431 10.1001/jama.278.17.1426 1:STN:280: DyaK1c%2Fhs1Skug%3D%3D 9356001
35. CH Ericsson J Juhasz B Mossberg K Philipson M Svartengren P Camner 1987 Influence of ambroxol on tracheobronchial clearance in simple chronic bronchitis Eur J Respir Dis 70 3 163 170 1:STN:280:DyaL2s7ptVyjtg%3D%3D 3569448 (Pubitemid 17029521)
36. Rubin BK (2003) Mucoactive agents for the treatment of cough. In: Chung F, Widdicombe J, Boushey H (eds) Cough: causes, mechanisms, and therapy. Blackwell Publishing, Oxford, pp 269-281
37. BK Rubin 2007 Designing clinical trials to evaluate mucus clearance therapy Respir Care 52 1348 1361 17894903